News
19h
Zacks Small Cap Research on MSNNRXBF Treatment Restores Mobility to Spinal Injury PatientsNRXBF READ THE FULL NRXBF RESEARCH REPORT NurExone (OTC:NRXBF) is developing a product known as ExoPTEN that is designed to treat patients with acute spinal cord injuries, while also conducting ...
Recent research introduces a soft, injectable material designed for use in the eye to help protect and support damaged ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results